4.7 Article

Abcg2 Expression Marks Tissue-Specific Stem Cells in Multiple Organs in a Mouse Progeny Tracking Model

Journal

STEM CELLS
Volume 30, Issue 2, Pages 210-221

Publisher

WILEY
DOI: 10.1002/stem.1002

Keywords

Abcg2; Stem cells; Intestine; Testis; Blood; Muscle

Funding

  1. Flow Cytometry and Cell Sorting Core
  2. Transgenic/Gene Knockout Core
  3. Animal Resource Center
  4. Institutes of Health Cancer Center [P30 CA 21765]
  5. National Institutes of Health [R01 HL67366]
  6. American Lebanese Syrian Associated Charities

Ask authors/readers for more resources

The side population phenotype is associated with the Hoechst dye efflux activity of the Abcg2 transporter and identifies hematopoietic stem cells (HSCs) in the bone marrow. This association suggests the direct use of Abcg2 expression to identify adult stem cells in various other organs. We have generated a lineage tracing mouse model based on an allele that coexpresses both Abcg2 and a CreERT2 expression cassette. By crossing these mice with lox-STOP-lox reporter lines (LacZ or YFP), cells that express Abcg2 and their progeny were identified following treatment with tamoxifen (Tam). In the liver and kidney, in which mature cells express Abcg2, reporter gene expression verified the expected physiologic expression pattern of the recombinant allele. Long-term marking of HSCs was seen in multiple peripheral blood lineages from adult mice, demonstrating that Abcg2+ bone marrow HSCs contribute to steady-state hematopoiesis. Stem cell tracing patterns were seen in the small intestine and in seminiferous tubules in the testis 20 months after Tam treatment, proving that stem cells from these organs express Abcg2. Interstitial cells from skeletal and cardiac muscle were labeled, and some cells were costained with endothelial markers, raising the possibility that these cells may function in the repair response to muscle injury. Altogether, these studies prove that Abcg2 is a stem cell marker for blood, small intestine, testicular germ cells, and possibly for injured skeletal and/or cardiac muscle and provide a new model for studying stem cell activity that does not require transplant-based assays. STEM CELLS 2012; 30:210221.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biotechnology & Applied Microbiology

Quantitative Shearing Linear Amplification Polymerase Chain Reaction: An Improved Method for Quantifying Lentiviral Vector Insertion Sites in Transplanted Hematopoietic Cell Systems

Sheng Zhou, Melissa A. Bonner, Yong-Dong Wang, Samuel Rapp, Suk See De Ravin, Harry L. Malech, Brian P. Sorrentino

HUMAN GENE THERAPY METHODS (2015)

Article Cell Biology

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency

Suk See De Ravin, Xiaolin Wu, Susan Moir, Sandra Anaya-O'Brien, Nana Kwatemaa, Patricia Littel, Narda Theobald, Uimook Choi, Ling Su, Martha Marquesen, Dianne Hilligoss, Janet Lee, Clarissa M. Buckner, Kol A. Zarember, Geraldine O'Connor, Daniel McVicar, Douglas Kuhns, Robert E. Throm, Sheng Zhou, Luigi D. Notarangelo, I. Celine Hanson, Mort J. Cowan, Elizabeth Kang, Coleen Hadigan, Michael Meagher, John T. Gray, Brian P. Sorrentino, Harry L. Malech

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Hematology

Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage-tracing mouse model

Soghra Fatima, Sheng Zhou, Brian P. Sorrentino

EXPERIMENTAL HEMATOLOGY (2018)

Article Medicine, General & Internal

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, Hossam Abdelsamed, Shane J. Cross, Guolian Kang, Zhijun Ma, Jose Condori, Jola Dowdy, Brandon Triplett, Chen Li, Gabriela Maron, Juan C. Aldave Becerra, Joseph A. Church, Elif Dokmeci, James T. Love, Ana C. da Matta Ain, Hedi van der Watt, Xing Tang, William Janssen, Byoung Y. Ryu, Suk See De Ravin, Mitchell J. Weiss, Benjamin Youngblood, Janel R. Long-Boyle, Stephen Gottschalk, Michael M. Meagher, Harry L. Malech, Jennifer M. Puck, Morton J. Cowan, Brian P. Sorrentino

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy

Yoonjeong Jang, Yoon-Sang Kim, Matthew M. Wielgosz, Francesca Ferrara, Zhijun Ma, Jose Condori, Lance E. Palmer, Xiwen Zhao, Guolian Kang, David J. Rawlings, Sheng Zhou, Byoung Y. Ryu

GENE THERAPY (2020)

Article Medicine, Research & Experimental

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media

Matthew Bauler, Jessica K. Roberts, Chang-Chih Wu, Baochang Fan, Francesca Ferrara, Bon Ham Yip, Shiyong Diao, Young-In Kim, Jennifer Moore, Sheng Zhou, Matthew M. Wielgosz, Byoung Ryu, Robert E. Throm

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Oncology

CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy

Zelda Ode, Jose Condori, Nicolas Peterson, Sheng Zhou, Giedre Krenciute

CANCERS (2020)

Article Medicine, Research & Experimental

The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing

Janice M. Riberdy, Sheng Zhou, Fei Zheng, Young-In Kim, Jennifer Moore, Abishek Vaidya, Robert E. Throm, April Sykes, Natasha Sahr, Challice L. Bonifant, Byoung Ryu, Stephen Gottschalk, Mireya Paulina Velasquez

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Oncology

Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells

Phuong Nguyen, Emmanuel Okeke, Michael Clay, Dalia Haydar, Julie Justice, Carla O'Reilly, Shondra Pruett-Miller, James Papizan, Jennifer Moore, Sheng Zhou, Robert Throm, Giedre Krenciute, Stephen Gottschalk, Christopher DeRenzo

MOLECULAR THERAPY-ONCOLYTICS (2020)

Article Medicine, Research & Experimental

3′ UTR-truncated HMGA2 overexpression induces non-malignant in vivo expansion of hematopoietic stem cells in non-human primates

Melissa A. Bonner, Antonio Morales-Hernandez, Sheng Zhou, Zhijun Ma, Jose Condori, Yong-Dong Wang, Soghra Fatima, Lance E. Palmer, Laura J. Janke, Stephanie Fowler, Brian P. Sorrentino, Shannon McKinney-Freeman

Summary: Vector-mediated mutagenesis remains a major safety concern for many gene therapy clinical protocols, but prolonged ectopic expression of HMGA2 in non-human primate HSCs is not sufficient to drive hematologic malignancy.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells

Young-In Kim-Hoehamer, Janice M. Riberdy, Fei Zheng, Jeoungeun J. Park, Na Shang, Jean-Yves Metais, Timothy Lockey, Catherine Willis, Salem Akel, Jennifer Moore, Michael M. Meagher, M. Paulina Velasquez, Brandon M. Triplett, Aimee C. Talleur, Stephen Gottschalk, Sheng Zhou

Summary: We have successfully developed a current good manufacturing practice-compliant process to manufacture allogeneic CD19-CAR T cells, which have shown potent antitumor activity in vitro and in vivo.

GENE THERAPY (2023)

Article Cell Biology

Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity

Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, Yiping Fan, Alejandro Allo Anido, Zhongzhen Yi, Phuong Nguyen, Haley Houke, Matthew Bell, Dalia Haydar, Charmaine Brown, Shannon K. Boi, Shanta Alli, Jeremy Chase Crawford, Janice M. Riberdy, Jeoungeun J. Park, Sheng Zhou, Mireya Paulina Velasquez, Chris DeRenzo, Cicera R. Lazzarotto, Shengdar Q. Tsai, Peter Vogel, Shondra M. Pruett-Miller, Deanna M. Langfitt, Stephen Gottschalk, Ben Youngblood, Giedre Krenciute

Summary: CAR T cell exhaustion occurs due to epigenetic repression of T cell multipotent potential, deletion of DNMT3A enhances CAR T cell functionality and upregulates interleukin-10, and a genome-wide DNA methylation profiling identifies genes targeted for epigenetic silencing that limits immune cell stemness. This epigenetically regulated multipotency program is crucial for the clinical outcome of CAR T cell therapies, highlighting the importance of leveraging epigenetic mechanisms to improve CAR T cell efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Hematology

Preferential expansion of CD8+CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL

Aimee C. Talleur, Amr Qudeimat, Jean-Yves Metais, Deanna Langfitt, Ewelina Mamcarz, Jeremy Chase Crawford, Sujuan Huang, Cheng Cheng, Caitlin Hurley, Renee Madden, Akshay Sharma, Ali Suliman, Ashok Srinivasan, M. Paulina Velasquez, Esther A. Obeng, Catherine Willis, Salem Akel, Seth E. Karol, Hiroto Inaba, Allison Bragg, Wenting Zheng, Sheng M. Zhou, Sarah Schell, Macal Tuggle-Brown, David Cullins, Sagar L. Patil, Ying Li, Paul G. Thomas, Caitlin Zebley, Benjamin Youngblood, Ching-Hon Pui, Timothy Lockey, Terrence L. Geiger, Michael M. Meagher, Brandon M. Triplett, Stephen Gottschalk

Summary: CD19-specific CAR T cells have potent antileukemia activity in pediatric and adult B-ALL patients, but not all patients achieve a complete response. This clinical study evaluated a new CD19-CAR T cell product in pediatric patients and showed that the treatment was safe and effective, with disease burden before infusion affecting the treatment outcome.

BLOOD ADVANCES (2022)

Article Multidisciplinary Sciences

Lentivector cryptic splicing mediates increase in CD34+clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency

Suk See De Ravin, Siyuan Liu, Colin L. Sweeney, Julie Brault, Narda Whiting-Theobald, Michelle Ma, Taylor Liu, Uimook Choi, Janet Lee, Sandra Anaya O'Brien, Priscilla Quackenbush, Tyra Estwick, Anita Karra, Ethan Docking, Nana Kwatemaa, Shuang Guo, Ling Su, Zhonghe Sun, Sheng Zhou, Jennifer Puck, Morton J. Cowan, Luigi D. Notarangelo, Elizabeth Kang, Harry L. Malech, Xiaolin Wu

Summary: De Ravin et al. report on the unintended consequences of lentiviral gene therapy in a clinical trial for the treatment of X-linked Severe Combined Immunodeficiency. They found that vector-induced alternative splicing events led to clonal dominance and clonal expansion. However, this issue can be mitigated by removing the splice acceptor. These findings highlight the importance of functional analysis of lentivectors for preclinical safety assessment and a redesign of clinical vectors to improve safety.

NATURE COMMUNICATIONS (2022)

Article Cell & Tissue Engineering

Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis

Salem Akel, Leigh Poston, Jeoungeun J. Park, Susan B. Schoultz, Lina Alloush, Fei Zheng, Sheng Zhou, Timothy Lockey, Catherine Willis, Christopher DeRenzo, Stephen Gottschalk

Summary: A simple thaw/wash procedure was developed and validated in this study for the preparation of B7-H3-CAR T cells for locoregional delivery. The quality, safety attributes, and stability of the products were assessed and met the desired specifications within 3 hours post thaw/wash, demonstrating the effectiveness of the procedure.

CYTOTHERAPY (2023)

No Data Available